Ketamine and Pregnancy: Taking a Look at the Practices of Ketamine Clinics
With ketamine and esketamine increasingly used to treat depression, especially in women of reproductive age, this study reveals important gaps in care, including inconsistencies in pregnancy testing, informed consent, and contraception practices among ketamine clinics in the United States.Â
Weekly Roundup for October 4, 2024: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
During Pregnancy: Buprenorphine or Buprenorphine Plus Naloxone?
In this large observational study, similar and, in some instances, more favorable neonatal and maternal outcomes were observed in pregnancies exposed to buprenorphine combined with naloxone compared to pregnancies exposed to buprenorphine alone.
Bridging the Gap: Addressing Ethnic and Racial Inequities in Perinatal Depression Treatment
This study provides valuable insight into the inequities in perinatal mental healthcare and suggests that the most significant barriers to mental healthcare may occur at the provider referral level.
Is it Safe for Breastfeeding Mothers to Use Benzodiazepines?
Clinically significant anxiety symptoms are common during the postpartum period and frequently complicate the treatment of postpartum depression.  While SSRIs are indicted for the treatment anxiety symptoms, especially when they co-occur with depression, many women may need to use a benzodiazepine for managing more severe symptoms of anxiety or insomnia.Â
Recruiting for Research Study: THRIVE (Targeting Health and Resilience for Individuals with a Vulnerable Eating History)
Do you have a history of an eating disorder or eating problems and are currently in your first or second trimester of pregnancy?